Fan Yu

Q1 2021 13F Combination Report, Restatement, Stock Holdings

Signature - Title
Fan Yu - Self
Location
Hong Kong, Hong Kong
Holdings as of
31 Mar 2021
Value $
$38,313,000
Num holdings
5
Filing time
17 Sep 2021, 15:08:28 UTC
Form type
13F-HR/A-1 - Restatement
Description
A portion of the US holdings for this investor are reported in this report and a portion are reported by other reporting manager(s). Top holdings included AVIR, LUNG, ABGI, AGLE, and DIFFUSION PHARMACEUTICALS IN.
Previous filing
Q4 2020 - 16 Feb 2021
Next filing
Q2 2021 - 17 Sep 2021
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2021 Q1 - Restatement compared to 2020 Q4 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Fan Yu Self New York, New York 17 Sep 2021

List of Other Managers Reporting for Fan Yu:

Name Holdings Value Location File Number
Ally Bridge Group (NY) LLC $62,997,127 New York, NY 028-20834
ABG Innovation Capital Partners III GP Ltd $64,532 Central, Hong Kong, Hong Kong 028-20837